US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akero Therapeutics

44.87

-0.4400-0.97%

Post-market: 44.870.00000.00%17:20 EDT

Volume:1.21M

Turnover:54.60M

Market Cap:3.57B

PE:-11.95

High:46.47

Open:45.51

Low:44.08

Close:45.31

Loading ...

Overview Company News Filings

Akero Therapeutics Shares Double Pre-Bell After Preliminary Results From Phase 2b Trial of Lead Product Candidate

MT Newswires Live

Akero Therapeutics Shares Jump 91% Premarket After Co Reports Prelim Mid-Stage Data on Liver Disease Drug

THOMSON REUTERS

Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversal of Compensated Cirrhosis (F4) Due to Mash—by Both Completer and ITT Analyses—at Week 96 in Phase 2B Symmetry Study

THOMSON REUTERS

Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversal of Compensated Cirrhosis (F4) Due to MASH—by Both Completer and ITT Analyses—at Week 96 in Phase 2b SYMMETRY Study

Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH

Akero Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Promising Developments in Akero Therapeutics’ EFX Fuel Buy Rating with $50 Price Target

Bank of America Securities Remains a Hold on Akero Therapeutics (AKRO)

Positive Outlook for Akero Therapeutics Based on Promising Clinical Trial Developments

Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 Synchrony Real-World Study Evaluating Efruxifermin (Efx) in Patients With Non-Invasively Diagnosed Mash or Masld

THOMSON REUTERS

Akero Therapeutics Inc - Data From Synchrony Real-World Study Expected in H1 2026

THOMSON REUTERS

Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 SYNCHRONY Real-World Study Evaluating Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD

Why Is Akero Therapeutics, Inc. (AKRO) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?

Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference

BUZZ-Akero Therapeutics rises after Citi initiates with 'buy' rating

Citigroup Initiates Akero Therapeutics at Buy With $65 Price Target

MT Newswires Live

Akero Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Promising Potential of Akero Therapeutics’ Efruxifermin Highlighted by Positive Phase 2b HARMONY Study Results

Akero Therapeutics (AKRO) Receives a Buy from Phillip Securities

Promising Clinical Trial Results and Future Potential Justify Buy Rating for Akero Therapeutics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AKRO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AKRO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKRO\",,,,,undefined,":{"symbol":"AKRO","market":"US","secType":"STK","nameCN":"Akero Therapeutics","latestPrice":44.87,"timestamp":1746216000000,"preClose":45.31,"halted":0,"volume":1212166,"hourTrading":{"tag":"盘后","latestPrice":44.87,"preClose":44.87,"latestTime":"17:20 EDT","volume":22850,"amount":1025236.5,"timestamp":1746220822640},"delay":0,"floatShares":66438593,"shares":79620128,"eps":-3.754425,"marketStatus":"Market Closed","change":-0.44,"latestTime":"05-02 16:00:00 EDT","open":45.51,"high":46.47,"low":44.08,"amount":54604748.479998,"amplitude":0.052748,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.754425,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"listingDate":1561003200000,"exchange":"NASDAQ","adjPreClose":45.31,"preHourTrading":{"tag":"盘前","latestPrice":45.56,"preClose":45.31,"latestTime":"09:29 EDT","volume":379,"amount":17266.1409,"timestamp":1746192599999},"postHourTrading":{"tag":"盘后","latestPrice":44.87,"preClose":44.87,"latestTime":"17:20 EDT","volume":22850,"amount":1025236.5,"timestamp":1746220822640},"volumeRatio":0.9420120460981588,"impliedVol":0.6877,"impliedVolPercentile":0.788},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKRO\",,,,,undefined,":{"symbol":"AKRO","floatShares":66438593,"roa":"-25.37%","roe":"-39.22%","lyrEps":-3.754425,"volumeRatio":0.9420120460981588,"shares":79620128,"dividePrice":0,"high":46.47,"amplitude":0.052748,"preClose":45.31,"low":44.08,"week52Low":17.86,"pbRate":"4.76","week52High":58.4,"institutionHeld":0,"latestPrice":44.87,"eps":-3.754425,"divideRate":0,"volume":1212166,"delay":0,"ttmEps":-3.754425,"open":45.51,"prevYearClose":27.82,"prevWeekClose":41,"prevMonthClose":45.61,"prevQuarterClose":40.48,"fiveDayClose":41,"twentyDayClose":39.99,"sixtyDayClose":57.56},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AKRO\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2506375348","title":"Akero Therapeutics Shares Double Pre-Bell After Preliminary Results From Phase 2b Trial of Lead Product Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2506375348","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506375348?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:48","pubTimestamp":1737978490,"startTime":"0","endTime":"0","summary":"Akero Therapeutics Shares Double Pre-Bell After Preliminary Results From Phase 2b Trial of Lead Product Candidate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","AKRO","BK4505","BK4139","BK4588"],"gpt_icon":0},{"id":"2506373773","title":"Akero Therapeutics Shares Jump 91% Premarket After Co Reports Prelim Mid-Stage Data on Liver Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2506373773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506373773?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:43","pubTimestamp":1737978214,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL3N3ON0OZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","AKRO","BK4588","BK4139"],"gpt_icon":0},{"id":"2506735653","title":"Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversal of Compensated Cirrhosis (F4) Due to Mash—by Both Completer and ITT Analyses—at Week 96 in Phase 2B Symmetry Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2506735653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506735653?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:30","pubTimestamp":1737977404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3OL088:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","AKRO","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2506929373","title":"Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversal of Compensated Cirrhosis (F4) Due to MASH—by Both Completer and ITT Analyses—at Week 96 in Phase 2b SYMMETRY Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2506929373","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506929373?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:30","pubTimestamp":1737977400,"startTime":"0","endTime":"0","summary":"Among patients with baseline and week 96 biopsies, 39% of the 50mg EFX group (p=0.009) demonstrated ≥1 stage improvement in fibrosis with no worsening of MASH, representing a 24% effect size over plac","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/27/3015438/0/en/Akero-Therapeutics-Reports-Preliminary-Topline-Results-Showing-Statistically-Significant-Reversal-of-Compensated-Cirrhosis-F4-Due-to-MASH-by-Both-Completer-and-ITT-Analyses-at-Week.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","BK4161","LU0054578231.USD","EFX","BK4505","LU0053671581.USD","BK4585","BK4588","BK4139","ITT","AKRO"],"gpt_icon":0},{"id":"2506481345","title":"Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2506481345","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506481345?lang=en_us&edition=fundamental","pubTime":"2025-01-25 05:05","pubTimestamp":1737752700,"startTime":"0","endTime":"0","summary":"Investor webcast on Monday, January 27, 2025, at 8:00 a.m. ET to present clinical data SOUTH SAN FRANCISCO, Calif., Jan.  24, 2025  (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clini","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/24/3015109/0/en/Akero-Therapeutics-to-Present-Preliminary-Topline-Week-96-Results-from-Phase-2b-SYMMETRY-Study-Investigating-Efruxifermin-in-Patients-with-Compensated-Cirrhosis-F4-Due-to-MASH.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","AKRO","BK4588","BK4139","BK4123","EFX","BK4505"],"gpt_icon":0},{"id":"2504917592","title":"Akero Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2504917592","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504917592?lang=en_us&edition=fundamental","pubTime":"2025-01-17 00:53","pubTimestamp":1737046380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AKRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 16, 2025 11:53 ET (16:53 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKRO"],"gpt_icon":0},{"id":"2504114914","title":"Promising Developments in Akero Therapeutics’ EFX Fuel Buy Rating with $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2504114914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504114914?lang=en_us&edition=fundamental","pubTime":"2025-01-17 00:05","pubTimestamp":1737043514,"startTime":"0","endTime":"0","summary":"Akero Therapeutics (AKRO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed Arce from H.C....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-developments-in-akero-therapeutics-efx-fuel-buy-rating-with-50-price-target?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-developments-in-akero-therapeutics-efx-fuel-buy-rating-with-50-price-target?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EFX","AKRO"],"gpt_icon":0},{"id":"2503392106","title":"Bank of America Securities Remains a Hold on Akero Therapeutics (AKRO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503392106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503392106?lang=en_us&edition=fundamental","pubTime":"2025-01-15 07:55","pubTimestamp":1736898911,"startTime":"0","endTime":"0","summary":"In a report released today, Jason Zemansky from Bank of America Securities maintained a Hold rating on Akero Therapeutics (AKRO – Research Report),...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-hold-on-akero-therapeutics-akro?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-hold-on-akero-therapeutics-akro?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505868.SGD","LU0306807586.USD","LU1496350502.SGD","LU2129689514.USD","LU0683600562.USD","BK4553","LU0130102774.USD","IE00B19Z3B42.SGD","LU0971096721.USD","IE00BKVL7J92.USD","AKRO","LU0640476718.USD","LU0787776722.HKD","LU0098860793.USD","IE00B19Z3581.USD","LU0477156797.USD","LU0256863902.USD","LU1280957306.USD","LU0320765489.SGD","BK4559","LU1201861165.SGD","IE0002270589.USD","LU1267930227.SGD","BK4588","LU1363072403.SGD","LU1894683348.USD","LU0106831901.USD","LU0128525689.USD","LU0053666078.USD","IE00B1BXHZ80.USD","LU0306806265.USD","BK4139","LU0980610538.SGD","LU0868494617.USD","LU1668664300.SGD","LU1366192091.USD","LU2129689431.USD","LU1074936037.SGD","LU0320765646.SGD","BAC","LU0234572021.USD","LU1894683264.USD","BK4581","LU1162221912.USD","LU1496350171.SGD","LU0648000940.SGD","LU0149725797.USD","LU0321505439.SGD","LU0130103400.USD","LU0070302665.USD"],"gpt_icon":0},{"id":"2503553398","title":"Positive Outlook for Akero Therapeutics Based on Promising Clinical Trial Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2503553398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503553398?lang=en_us&edition=fundamental","pubTime":"2025-01-14 04:36","pubTimestamp":1736800572,"startTime":"0","endTime":"0","summary":"Analyst Michael Ulz from Morgan Stanley maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) and keeping the price target at $46....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-outlook-for-akero-therapeutics-based-on-promising-clinical-trial-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-outlook-for-akero-therapeutics-based-on-promising-clinical-trial-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2357305700.SGD","LU2271345857.HKD","LU0006306889.USD","LU0314104364.USD","BK4505","BK4127","LU0158827781.USD","LU1363072403.SGD","LU2089283258.USD","LU2347655156.SGD","BK4139","LU0158827948.USD","LU1720051017.SGD","LU0795875086.SGD","LU1548497426.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","AKRO","LU1074936037.SGD","LU2028103732.USD","LU0267386448.USD","BK4588","LU0098860793.USD","LU0106261372.USD","LU1162221912.USD","LU0106831901.USD","LU1668664300.SGD","LU1989772840.SGD","LU0912757837.SGD","LU2111349929.HKD","BK4516","LU0320765646.SGD","BK4581","LU1732800096.USD","LU1989772923.USD","LU1732799900.SGD","BK4504","LU2023251221.USD","LU1720051108.HKD","BK4534","LU0971096721.USD","LU2089284900.SGD","LU0795875169.SGD","LU0225283273.USD","BK4585"],"gpt_icon":0},{"id":"2503130818","title":"Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 Synchrony Real-World Study Evaluating Efruxifermin (Efx) in Patients With Non-Invasively Diagnosed Mash or Masld","url":"https://stock-news.laohu8.com/highlight/detail?id=2503130818","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503130818?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:00","pubTimestamp":1736769602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA5GH8V2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKRO","BK4139","BK4588","BK4585","BK4505"],"gpt_icon":0},{"id":"2503084823","title":"Akero Therapeutics Inc - Data From Synchrony Real-World Study Expected in H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2503084823","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503084823?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:00","pubTimestamp":1736769602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250113:nTUA5GH8V2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKRO","BK4585","BK4505","BK4588","BK4139"],"gpt_icon":0},{"id":"2503303100","title":"Akero Therapeutics Completes Enrollment of the Double-Blind Portion of the Phase 3 SYNCHRONY Real-World Study Evaluating Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD","url":"https://stock-news.laohu8.com/highlight/detail?id=2503303100","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503303100?lang=en_us&edition=fundamental","pubTime":"2025-01-13 20:00","pubTimestamp":1736769600,"startTime":"0","endTime":"0","summary":"-- 601 patients have been enrolled in the double-blind portion of the SYNCHRONY Real-World study since initiation in November 2023 -- -- Data from SYNCHRONY Real-World study anticipated in the first h","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/13/3008318/0/en/Akero-Therapeutics-Completes-Enrollment-of-the-Double-Blind-Portion-of-the-Phase-3-SYNCHRONY-Real-World-Study-Evaluating-Efruxifermin-EFX-in-Patients-with-Non-Invasively-Diagnosed-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","EFX","BK4139","BK4166","SYF","BK4123","AKRO","LU1668664300.SGD","BK4585","BK4588","LU1861220207.SGD","LU0106831901.USD","LU1861217088.USD","BK4561"],"gpt_icon":0},{"id":"2489605148","title":"Why Is Akero Therapeutics, Inc. (AKRO) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2489605148","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489605148?lang=en_us&edition=fundamental","pubTime":"2024-12-05 01:59","pubTimestamp":1733335174,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.In this article, we are going to take a look at where Akero Therapeutics, Inc.  stands against the other small-cap biotech stocks.Revolutionizing Healthcare and Economy: The Rapid Growth of Biotechnology. The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance. Advances in fields like gene editing, sequencing, personalized medicine, and artificial intelligence are making new techniques possible, while the aging population and growing healthcare demands are driving a robust market for new treatments. According to a report by McKinsey & Company, venture capital firms made approximately $52 billion in global investments in therapeutic-focused biotech companies between 2019 and 2021. Two-thirds of this sum was given to platform-tech start-up companies.This year  started strongly for the biotechn","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B8nNKitq5.bBLQV_JsrbbA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ac2e6567c554c8e493f33479515309b7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B8nNKitq5.bBLQV_JsrbbA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ac2e6567c554c8e493f33479515309b7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-akero-therapeutics-inc-akro-175934136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AKRO","BK4585","CAGR","SQQQ","TQQQ","QID","BK4159","NQmain","BK4505","BK4123","QLD","BK4588","MNQmain","BK4139","PSQ","EFX",".IXIC"],"gpt_icon":1},{"id":"2486071674","title":"Akero Therapeutics to Present at the 7th Annual Evercore ISI HealthCONx Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2486071674","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486071674?lang=en_us&edition=fundamental","pubTime":"2024-11-26 20:00","pubTimestamp":1732622400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Nov.  26, 2024  (GLOBE NEWSWIRE) -- Akero Therapeutics,Inc.(Nasdaq: AKRO),a clinical-stage company developing transformational treatments for patients with serious metabol","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/26/2987347/0/en/Akero-Therapeutics-to-Present-at-the-7th-Annual-Evercore-ISI-HealthCONx-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","AKRO","BK4505","BK4139"],"gpt_icon":0},{"id":"2484169677","title":"BUZZ-Akero Therapeutics rises after Citi initiates with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2484169677","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484169677?lang=en_us&edition=fundamental","pubTime":"2024-11-19 00:01","pubTimestamp":1731945676,"startTime":"0","endTime":"0","summary":"BUZZ-Akero Therapeutics rises after Citi initiates with 'buy' rating** Drug developer Akero Therapeutics' AKRO.O shares rise ~2.5% to $28.78** Citi initiates coverage of AKRO with \"buy\" rating** Broke","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4N3MP14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKRO"],"gpt_icon":0},{"id":"2484570627","title":"Citigroup Initiates Akero Therapeutics at Buy With $65 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2484570627","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484570627?lang=en_us&edition=fundamental","pubTime":"2024-11-18 21:20","pubTimestamp":1731936056,"startTime":"0","endTime":"0","summary":"Akero Therapeutics (AKRO) has an average buy rating and a price target range of $35 to $65, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic research from","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKRO"],"gpt_icon":0},{"id":"2484272621","title":"Akero Therapeutics Price Target Maintained With a $50.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2484272621","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484272621?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:42","pubTimestamp":1731933720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AKRO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 18, 2024 07:42 ET (12:42 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKRO"],"gpt_icon":0},{"id":"2484562588","title":"Promising Potential of Akero Therapeutics’ Efruxifermin Highlighted by Positive Phase 2b HARMONY Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2484562588","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484562588?lang=en_us&edition=fundamental","pubTime":"2024-11-18 19:35","pubTimestamp":1731929712,"startTime":"0","endTime":"0","summary":"Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) and keeping the price target at $50.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-potential-of-akero-therapeutics-efruxifermin-highlighted-by-positive-phase-2b-harmony-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-potential-of-akero-therapeutics-efruxifermin-highlighted-by-positive-phase-2b-harmony-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4505","BK4585","AKRO"],"gpt_icon":0},{"id":"2484644037","title":"Akero Therapeutics (AKRO) Receives a Buy from Phillip Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2484644037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484644037?lang=en_us&edition=fundamental","pubTime":"2024-11-18 18:18","pubTimestamp":1731925094,"startTime":"0","endTime":"0","summary":"Akero Therapeutics (AKRO – Research Report) received a Buy rating and a $65.00 price target from Phillip Securities analyst Jonathan Woo today. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/akero-therapeutics-akro-receives-a-buy-from-phillip-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/akero-therapeutics-akro-receives-a-buy-from-phillip-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","AKRO","BK4139","BK4505","BK4588"],"gpt_icon":0},{"id":"2484636621","title":"Promising Clinical Trial Results and Future Potential Justify Buy Rating for Akero Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2484636621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484636621?lang=en_us&edition=fundamental","pubTime":"2024-11-17 22:35","pubTimestamp":1731854139,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Michael Ulz maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) on November 15 and set a price target of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/promising-clinical-trial-results-and-future-potential-justify-buy-rating-for-akero-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/promising-clinical-trial-results-and-future-potential-justify-buy-rating-for-akero-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AKRO"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":112,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AKRO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-28","symbol":"AKRO","fiscalQuarterEnding":"2024/12","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":-0.99},{"market":"US","date":"2024-11-08","symbol":"AKRO","fiscalQuarterEnding":"2024/09","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":-1.05},{"market":"US","date":"2024-08-09","symbol":"AKRO","fiscalQuarterEnding":"2024/06","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"pre","actualEps":-0.81},{"market":"US","date":"2024-05-10","symbol":"AKRO","fiscalQuarterEnding":"2024/03","expectedEps":-0.9,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715313600000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2024-02-29","symbol":"AKRO","fiscalQuarterEnding":"2023/12","expectedEps":-0.82,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1709182800000,"reportTimeType":"pre","actualEps":-0.99}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AKRO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AKRO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1738296000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AKRO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AKRO","date":"2025-05-02","current":-14.312418,"percent":0.375,"low":-29.91201,"twenty":-17.33271,"median":-11.525934,"eighty":-7.676374,"high":-2.507998,"avg":-12.541217,"sd":5.780809,"marketCap":3607587999},"quantilePoints":[{"date":"2020-05-08","current":-14.422434,"twenty":-9.261983,"median":-7.318442,"eighty":-6.362726,"marketCap":631053596},{"date":"2020-05-15","current":-13.110982,"twenty":-9.53678,"median":-7.35509,"eighty":-6.365942,"marketCap":659207075},{"date":"2020-05-22","current":-13.806737,"twenty":-9.901479,"median":-7.369052,"eighty":-6.375279,"marketCap":694188921},{"date":"2020-05-29","current":-14.496789,"twenty":-10.712194,"median":-7.380584,"eighty":-6.38292,"marketCap":728884030},{"date":"2020-06-05","current":-13.71549,"twenty":-11.067873,"median":-7.469773,"eighty":-6.391425,"marketCap":689601138},{"date":"2020-06-12","current":-13.846657,"twenty":-12.625272,"median":-7.518792,"eighty":-6.400409,"marketCap":696196076},{"date":"2020-06-19","current":-15.260978,"twenty":-12.88267,"median":-7.549483,"eighty":-6.404911,"marketCap":767306713},{"date":"2020-06-26","current":-13.40183,"twenty":-13.042334,"median":-7.603658,"eighty":-6.408616,"marketCap":673830634},{"date":"2020-07-02","current":-18.830998,"twenty":-13.215916,"median":-7.63797,"eighty":-6.408616,"marketCap":946803724},{"date":"2020-07-10","current":-29.91201,"twenty":-13.366345,"median":-7.670581,"eighty":-6.411064,"marketCap":1503945932},{"date":"2020-07-17","current":-25.067707,"twenty":-13.588413,"median":-7.75905,"eighty":-6.422869,"marketCap":1260379245},{"date":"2020-07-24","current":-24.137276,"twenty":-13.713207,"median":-7.778082,"eighty":-6.43411,"marketCap":1213598090},{"date":"2020-07-31","current":-23.67206,"twenty":-13.83179,"median":-7.800664,"eighty":-6.450044,"marketCap":1190207512},{"date":"2020-08-07","current":-23.705771,"twenty":-13.881461,"median":-7.829142,"eighty":-6.46534,"marketCap":1191902482},{"date":"2020-08-14","current":-19.904133,"twenty":-14.005803,"median":-7.861788,"eighty":-6.476175,"marketCap":1179479138},{"date":"2020-08-21","current":-20.226207,"twenty":-14.199691,"median":-7.935084,"eighty":-6.483186,"marketCap":1198564561},{"date":"2020-08-28","current":-18.855931,"twenty":-14.270544,"median":-8.050767,"eighty":-6.503582,"marketCap":1117364761},{"date":"2020-09-04","current":-18.937913,"twenty":-14.36582,"median":-8.147976,"eighty":-6.526026,"marketCap":1122222869},{"date":"2020-09-11","current":-19.927557,"twenty":-14.422434,"median":-8.307937,"eighty":-6.575009,"marketCap":1180867169},{"date":"2020-09-18","current":-21.666753,"twenty":-14.622252,"median":-8.363107,"eighty":-6.57836,"marketCap":1283928453},{"date":"2020-09-25","current":-18.81494,"twenty":-15.118405,"median":-8.41206,"eighty":-6.580702,"marketCap":1114935707},{"date":"2020-10-02","current":-16.976194,"twenty":-16.976194,"median":-8.578813,"eighty":-6.611776,"marketCap":1005975293},{"date":"2020-10-09","current":-16.870788,"twenty":-17.0816,"median":-8.690351,"eighty":-6.611872,"marketCap":999729154},{"date":"2020-10-16","current":-16.601418,"twenty":-17.0816,"median":-8.720367,"eighty":-6.615223,"marketCap":983766801},{"date":"2020-10-23","current":-15.365827,"twenty":-16.976194,"median":-8.806893,"eighty":-6.645384,"marketCap":910548178},{"date":"2020-10-30","current":-15.547359,"twenty":-16.941059,"median":-8.939265,"eighty":-6.647202,"marketCap":921305416},{"date":"2020-11-06","current":-16.894211,"twenty":-16.941059,"median":-9.038124,"eighty":-6.668842,"marketCap":1001117185},{"date":"2020-11-13","current":-14.879191,"twenty":-16.976194,"median":-9.235843,"eighty":-6.682628,"marketCap":968739475},{"date":"2020-11-20","current":-15.428494,"twenty":-16.941059,"median":-9.436914,"eighty":-6.688949,"marketCap":1004502975},{"date":"2020-11-27","current":-15.588486,"twenty":-16.903581,"median":-9.520694,"eighty":-6.691622,"marketCap":1014919529},{"date":"2020-12-04","current":-15.204506,"twenty":-16.875473,"median":-9.616202,"eighty":-6.692298,"marketCap":989919800},{"date":"2020-12-11","current":-15.097846,"twenty":-16.852049,"median":-10.013317,"eighty":-6.694801,"marketCap":982975431},{"date":"2020-12-18","current":-13.593927,"twenty":-16.83331,"median":-10.683426,"eighty":-6.715821,"marketCap":885059829},{"date":"2020-12-24","current":-13.903244,"twenty":-16.815743,"median":-10.944954,"eighty":-6.749994,"marketCap":905198499},{"date":"2020-12-31","current":-13.759252,"twenty":-16.77358,"median":-11.062642,"eighty":-6.770718,"marketCap":895823601},{"date":"2021-01-08","current":-15.407162,"twenty":-16.675202,"median":-11.708067,"eighty":-6.783453,"marketCap":1003114102},{"date":"2021-01-15","current":-15.593819,"twenty":-16.56394,"median":-12.66777,"eighty":-6.808882,"marketCap":1015266747},{"date":"2021-01-22","current":-16.564432,"twenty":-16.55309,"median":-12.785067,"eighty":-6.826938,"marketCap":1078460505},{"date":"2021-01-29","current":-15.689813,"twenty":-16.548824,"median":-12.912954,"eighty":-6.843773,"marketCap":1021516679},{"date":"2021-02-05","current":-16.772421,"twenty":-16.548824,"median":-12.968433,"eighty":-6.849136,"marketCap":1092002025},{"date":"2021-02-12","current":-16.61243,"twenty":-16.701999,"median":-13.076409,"eighty":-6.867232,"marketCap":1081585471},{"date":"2021-02-19","current":-16.841751,"twenty":-16.756422,"median":-13.193949,"eighty":-6.896722,"marketCap":1096515865},{"date":"2021-02-26","current":-16.212452,"twenty":-16.724391,"median":-13.254083,"eighty":-6.912127,"marketCap":1055544088},{"date":"2021-03-05","current":-16.292447,"twenty":-16.724391,"median":-13.36191,"eighty":-6.921687,"marketCap":1060752364},{"date":"2021-03-12","current":-17.588377,"twenty":-16.829797,"median":-13.391272,"eighty":-6.937621,"marketCap":1145126448},{"date":"2021-03-19","current":-13.928847,"twenty":-16.829797,"median":-13.442548,"eighty":-6.940272,"marketCap":1103262221},{"date":"2021-03-26","current":-12.857735,"twenty":-16.806373,"median":-13.422189,"eighty":-6.953692,"marketCap":1018422643},{"date":"2021-04-01","current":-12.572398,"twenty":-16.779211,"median":-13.391272,"eighty":-6.986725,"marketCap":995821936},{"date":"2021-04-09","current":-12.186095,"twenty":-16.759622,"median":-13.36191,"eighty":-7.005181,"marketCap":965224055},{"date":"2021-04-16","current":-12.001724,"twenty":-16.730797,"median":-13.254083,"eighty":-7.010076,"marketCap":950620521},{"date":"2021-04-23","current":-12.712872,"twenty":-16.720151,"median":-13.193949,"eighty":-7.021386,"marketCap":1006948438},{"date":"2021-04-30","current":-13.540038,"twenty":-16.633762,"median":-13.251873,"eighty":-7.026294,"marketCap":1072465825},{"date":"2021-05-07","current":-12.014586,"twenty":-16.60362,"median":-13.236613,"eighty":-7.029401,"marketCap":951639318},{"date":"2021-05-14","current":-11.921269,"twenty":-16.571829,"median":-13.105079,"eighty":-7.033304,"marketCap":982443660},{"date":"2021-05-21","current":-11.376127,"twenty":-16.560166,"median":-13.053953,"eighty":-7.044844,"marketCap":937518019},{"date":"2021-05-28","current":-11.06341,"twenty":-16.517998,"median":-12.952173,"eighty":-7.052887,"marketCap":911746722},{"date":"2021-06-04","current":-11.333868,"twenty":-16.442554,"median":-12.927349,"eighty":-7.056239,"marketCap":934035411},{"date":"2021-06-11","current":-12.242437,"twenty":-16.386309,"median":-12.863037,"eighty":-7.062087,"marketCap":1008911479},{"date":"2021-06-18","current":-12.656575,"twenty":-16.339378,"median":-12.82894,"eighty":-7.068627,"marketCap":1043041036},{"date":"2021-06-25","current":-11.680392,"twenty":-16.310686,"median":-12.749498,"eighty":-7.072229,"marketCap":962592795},{"date":"2021-07-02","current":-10.446429,"twenty":-16.298918,"median":-12.723847,"eighty":-7.100785,"marketCap":860900648},{"date":"2021-07-09","current":-10.598561,"twenty":-16.260449,"median":-12.670345,"eighty":-7.129444,"marketCap":873438036},{"date":"2021-07-16","current":-9.436438,"twenty":-16.199652,"median":-12.638245,"eighty":-7.161301,"marketCap":777666321},{"date":"2021-07-23","current":-9.453342,"twenty":-16.168478,"median":-12.57922,"eighty":-7.187024,"marketCap":779059364},{"date":"2021-07-30","current":-9.060333,"twenty":-16.147558,"median":-12.479088,"eighty":-7.19254,"marketCap":746671112},{"date":"2021-08-06","current":-8.650421,"twenty":-16.123923,"median":-12.447136,"eighty":-7.202393,"marketCap":712889816},{"date":"2021-08-13","current":-6.907372,"twenty":-16.075119,"median":-12.414365,"eighty":-7.202393,"marketCap":657146683},{"date":"2021-08-20","current":-7.651243,"twenty":-16.028851,"median":-12.339604,"eighty":-7.202393,"marketCap":727916325},{"date":"2021-08-27","current":-8.431758,"twenty":-16.00233,"median":-12.242437,"eighty":-7.220693,"marketCap":802172157},{"date":"2021-09-03","current":-8.688265,"twenty":-15.99913,"median":-12.199253,"eighty":-7.26547,"marketCap":826575483},{"date":"2021-09-10","current":-9.171964,"twenty":-15.99913,"median":-12.102589,"eighty":-7.303321,"marketCap":872593181},{"date":"2021-09-17","current":-9.120663,"twenty":-15.987397,"median":-12.018464,"eighty":-7.305372,"marketCap":867712516},{"date":"2021-09-24","current":-8.695594,"twenty":-15.935133,"median":-11.995139,"eighty":-7.310459,"marketCap":827272720},{"date":"2021-10-01","current":-8.123949,"twenty":-15.911668,"median":-11.92972,"eighty":-7.311204,"marketCap":772888167},{"date":"2021-10-08","current":-7.739189,"twenty":-15.883512,"median":-11.872224,"eighty":-7.316577,"marketCap":736283180},{"date":"2021-10-15","current":-7.819805,"twenty":-15.801967,"median":-11.811395,"eighty":-7.327046,"marketCap":743952796},{"date":"2021-10-22","current":-7.775832,"twenty":-15.787905,"median":-11.732424,"eighty":-7.334694,"marketCap":739769369},{"date":"2021-10-29","current":-7.874771,"twenty":-15.770876,"median":-11.680392,"eighty":-7.355909,"marketCap":749182080},{"date":"2021-11-05","current":-9.615355,"twenty":-15.731411,"median":-11.556183,"eighty":-7.359781,"marketCap":914776072},{"date":"2021-11-12","current":-9.011673,"twenty":-15.722879,"median":-11.376127,"eighty":-7.364919,"marketCap":883720689},{"date":"2021-11-19","current":-8.833788,"twenty":-15.702613,"median":-11.283252,"eighty":-7.376232,"marketCap":866276538},{"date":"2021-11-26","current":-7.517436,"twenty":-15.689813,"median":-11.181736,"eighty":-7.377397,"marketCap":737189821},{"date":"2021-12-03","current":-7.079838,"twenty":-15.68448,"median":-11.131025,"eighty":-7.362163,"marketCap":694277209},{"date":"2021-12-10","current":-7.072722,"twenty":-15.600062,"median":-11.076102,"eighty":-7.35509,"marketCap":693579443},{"date":"2021-12-17","current":-7.513878,"twenty":-15.593819,"median":-10.951492,"eighty":-7.326409,"marketCap":736840938},{"date":"2021-12-23","current":-7.809168,"twenty":-15.589553,"median":-10.907052,"eighty":-7.328958,"marketCap":765798228},{"date":"2021-12-31","current":-7.524551,"twenty":-15.555584,"median":-10.8249,"eighty":-7.349991,"marketCap":737887587},{"date":"2022-01-07","current":-7.094069,"twenty":-15.529063,"median":-10.598561,"eighty":-7.323951,"marketCap":695672741},{"date":"2022-01-14","current":-7.919457,"twenty":-15.524489,"median":-10.497139,"eighty":-7.31339,"marketCap":776613602},{"date":"2022-01-21","current":-7.090511,"twenty":-15.520644,"median":-10.431639,"eighty":-7.303711,"marketCap":695323858},{"date":"2022-01-28","current":-5.873775,"twenty":-15.486728,"median":-10.188649,"eighty":-7.264127,"marketCap":576005866},{"date":"2022-02-04","current":-6.332719,"twenty":-15.443427,"median":-10.07455,"eighty":-7.206289,"marketCap":621011775},{"date":"2022-02-11","current":-6.585316,"twenty":-15.415695,"median":-9.939321,"eighty":-7.186417,"marketCap":645782470},{"date":"2022-02-18","current":-6.311373,"twenty":-15.394363,"median":-9.66909,"eighty":-7.140107,"marketCap":618918477},{"date":"2022-02-25","current":-6.253737,"twenty":-15.38583,"median":-9.608238,"eighty":-7.1083,"marketCap":630232830},{"date":"2022-03-04","current":-5.301779,"twenty":-15.38583,"median":-9.546312,"eighty":-7.077703,"marketCap":534297388},{"date":"2022-03-11","current":-4.936978,"twenty":-15.382514,"median":-9.469024,"eighty":-7.069892,"marketCap":497533806},{"date":"2022-03-18","current":-5.121116,"twenty":-15.377539,"median":-9.443129,"eighty":-7.055568,"marketCap":516090661},{"date":"2022-03-25","current":-4.971721,"twenty":-15.372854,"median":-9.419629,"eighty":-7.028126,"marketCap":501035099},{"date":"2022-04-01","current":-5.17323,"twenty":-15.363485,"median":-9.339243,"eighty":-7.008112,"marketCap":521342602},{"date":"2022-04-08","current":-4.818852,"twenty":-15.355382,"median":-9.307822,"eighty":-6.94564,"marketCap":485629408},{"date":"2022-04-14","current":-4.28381,"twenty":-15.348499,"median":-9.246189,"eighty":-6.914039,"marketCap":431709488},{"date":"2022-04-22","current":-3.543784,"twenty":-15.346366,"median":-9.225135,"eighty":-6.867232,"marketCap":357131937},{"date":"2022-04-29","current":-3.64558,"twenty":-15.3325,"median":-9.206127,"eighty":-6.806449,"marketCap":367390588},{"date":"2022-05-06","current":-3.498657,"twenty":-15.301129,"median":-9.171964,"eighty":-6.770047,"marketCap":390855954},{"date":"2022-05-13","current":-2.943762,"twenty":-15.260978,"median":-9.104173,"eighty":-6.692925,"marketCap":328865359},{"date":"2022-05-20","current":-2.812093,"twenty":-15.249684,"median":-9.060333,"eighty":-6.685735,"marketCap":314155726},{"date":"2022-05-27","current":-2.771338,"twenty":-15.202373,"median":-9.033589,"eighty":-6.645748,"marketCap":309602745},{"date":"2022-06-03","current":-2.636533,"twenty":-15.19384,"median":-9.016208,"eighty":-6.611776,"marketCap":294542883},{"date":"2022-06-10","current":-2.677288,"twenty":-15.119178,"median":-8.977752,"eighty":-6.575009,"marketCap":299095864},{"date":"2022-06-17","current":-3.812157,"twenty":-15.118405,"median":-8.904459,"eighty":-6.496374,"marketCap":425878889},{"date":"2022-06-24","current":-3.257262,"twenty":-15.1149,"median":-8.876052,"eighty":-6.461681,"marketCap":363888294},{"date":"2022-07-01","current":-3.182022,"twenty":-15.109614,"median":-8.838505,"eighty":-6.428909,"marketCap":355482790},{"date":"2022-07-08","current":-3.583302,"twenty":-15.108306,"median":-8.833788,"eighty":-6.408616,"marketCap":400312147},{"date":"2022-07-15","current":-3.461037,"twenty":-15.105175,"median":-8.808041,"eighty":-6.393968,"marketCap":386653202},{"date":"2022-07-22","current":-3.388932,"twenty":-15.099979,"median":-8.787204,"eighty":-6.362726,"marketCap":378597927},{"date":"2022-07-29","current":-3.210237,"twenty":-15.097846,"median":-8.743696,"eighty":-6.329033,"marketCap":358634854},{"date":"2022-08-05","current":-4.69873,"twenty":-15.097846,"median":-8.71306,"eighty":-6.313508,"marketCap":517734250},{"date":"2022-08-12","current":-4.535059,"twenty":-15.044382,"median":-8.694273,"eighty":-6.274771,"marketCap":499699965},{"date":"2022-08-19","current":-4.105421,"twenty":-14.963008,"median":-8.688265,"eighty":-6.239603,"marketCap":452359969},{"date":"2022-08-26","current":-4.054274,"twenty":-14.926121,"median":-8.634099,"eighty":-6.193714,"marketCap":446724255},{"date":"2022-09-02","current":-4.32024,"twenty":-14.912256,"median":-8.59971,"eighty":-6.178935,"marketCap":476029967},{"date":"2022-09-09","current":-3.992897,"twenty":-14.90191,"median":-8.578813,"eighty":-6.162895,"marketCap":439961398},{"date":"2022-09-16","current":-10.688857,"twenty":-14.889272,"median":-8.589261,"eighty":-6.162895,"marketCap":1177762358},{"date":"2022-09-23","current":-10.914994,"twenty":-14.870658,"median":-8.620242,"eighty":-6.168247,"marketCap":1202679497},{"date":"2022-09-30","current":-14.344096,"twenty":-14.841176,"median":-8.669343,"eighty":-6.172565,"marketCap":1580518599},{"date":"2022-10-07","current":-16.06286,"twenty":-14.90191,"median":-8.692953,"eighty":-6.178291,"marketCap":1769902325},{"date":"2022-10-14","current":-16.218729,"twenty":-15.062203,"median":-8.706159,"eighty":-6.181075,"marketCap":1787076830},{"date":"2022-10-21","current":-17.899579,"twenty":-15.106172,"median":-8.733167,"eighty":-6.182581,"marketCap":1972282974},{"date":"2022-10-28","current":-17.191852,"twenty":-15.118869,"median":-8.777975,"eighty":-6.184494,"marketCap":1894301439},{"date":"2022-11-04","current":-14.82271,"twenty":-15.238389,"median":-8.806893,"eighty":-6.191427,"marketCap":1799447397},{"date":"2022-11-11","current":-15.654754,"twenty":-15.241294,"median":-8.830394,"eighty":-6.202112,"marketCap":1900455879},{"date":"2022-11-18","current":-17.018382,"twenty":-15.344233,"median":-8.838505,"eighty":-6.217951,"marketCap":2065997557},{"date":"2022-11-25","current":-17.657823,"twenty":-15.364656,"median":-8.871485,"eighty":-6.233151,"marketCap":2143624446},{"date":"2022-12-02","current":-17.511445,"twenty":-15.38583,"median":-8.904459,"eighty":-6.23543,"marketCap":2125854435},{"date":"2022-12-09","current":-16.544579,"twenty":-15.45836,"median":-8.977752,"eighty":-6.245769,"marketCap":2008478838},{"date":"2022-12-16","current":-18.085402,"twenty":-15.542785,"median":-9.016208,"eighty":-6.25566,"marketCap":2195531582},{"date":"2022-12-23","current":-18.817292,"twenty":-15.598813,"median":-9.038124,"eighty":-6.265634,"marketCap":2284381636},{"date":"2022-12-30","current":-21.109265,"twenty":-15.689813,"median":-9.060333,"eighty":-6.274771,"marketCap":2562622592},{"date":"2023-01-06","current":-17.264914,"twenty":-15.742077,"median":-9.087684,"eighty":-6.274771,"marketCap":2095925996},{"date":"2023-01-13","current":-19.352728,"twenty":-15.90285,"median":-9.158407,"eighty":-6.274771,"marketCap":2349382464},{"date":"2023-01-20","current":-18.486015,"twenty":-15.963932,"median":-9.185876,"eighty":-6.286244,"marketCap":2244165296},{"date":"2023-01-27","current":-18.971374,"twenty":-16.002649,"median":-9.222439,"eighty":-6.304381,"marketCap":2303086910},{"date":"2023-02-03","current":-18.474459,"twenty":-16.075766,"median":-9.235843,"eighty":-6.313508,"marketCap":2242762400},{"date":"2023-02-10","current":-17.045347,"twenty":-16.146079,"median":-9.286111,"eighty":-6.317604,"marketCap":2069270980},{"date":"2023-02-17","current":-17.330399,"twenty":-16.214963,"median":-9.33713,"eighty":-6.321298,"marketCap":2103875738},{"date":"2023-02-24","current":-16.113149,"twenty":-16.271575,"median":-9.402821,"eighty":-6.324353,"marketCap":1956104070},{"date":"2023-03-03","current":-18.328081,"twenty":-16.390575,"median":-9.436914,"eighty":-6.328362,"marketCap":2224992389},{"date":"2023-03-10","current":-15.92825,"twenty":-16.526424,"median":-9.449269,"eighty":-6.331311,"marketCap":1933657741},{"date":"2023-03-17","current":-16.866842,"twenty":-16.526424,"median":-9.48048,"eighty":-6.341408,"marketCap":1889642887},{"date":"2023-03-24","current":-15.701298,"twenty":-16.526424,"median":-9.55361,"eighty":-6.35699,"marketCap":1759063538},{"date":"2023-03-31","current":-16.040899,"twenty":-16.526424,"median":-9.615355,"eighty":-6.362089,"marketCap":1797110039},{"date":"2023-04-06","current":-15.466512,"twenty":-16.503004,"median":-9.706896,"eighty":-6.364648,"marketCap":1732759784},{"date":"2023-04-14","current":-15.948662,"twenty":-16.467122,"median":-9.922422,"eighty":-6.369917,"marketCap":1786776421},{"date":"2023-04-21","current":-17.914993,"twenty":-16.543441,"median":-10.07455,"eighty":-6.38178,"marketCap":2007070359},{"date":"2023-04-28","current":-18.292327,"twenty":-16.600066,"median":-10.178084,"eighty":-6.388881,"marketCap":2049344250},{"date":"2023-05-05","current":-19.341759,"twenty":-16.723331,"median":-10.416848,"eighty":-6.399732,"marketCap":2166915288},{"date":"2023-05-12","current":-19.709144,"twenty":-16.793458,"median":-10.497139,"eighty":-6.403676,"marketCap":2208074572},{"date":"2023-05-19","current":-21.880003,"twenty":-16.846241,"median":-10.598561,"eighty":-6.408616,"marketCap":2446950172},{"date":"2023-05-26","current":-21.673083,"twenty":-16.877694,"median":-10.76971,"eighty":-6.408616,"marketCap":2423809191},{"date":"2023-06-02","current":-22.321148,"twenty":-16.89619,"median":-10.850255,"eighty":-6.408616,"marketCap":2496285567},{"date":"2023-06-09","current":-25.556527,"twenty":-16.941059,"median":-10.907052,"eighty":-6.418104,"marketCap":2858114193},{"date":"2023-06-16","current":-27.312734,"twenty":-16.969744,"median":-10.944954,"eighty":-6.420855,"marketCap":3054519640},{"date":"2023-06-23","current":-25.729674,"twenty":-16.984484,"median":-11.032612,"eighty":-6.428909,"marketCap":2877478110},{"date":"2023-06-30","current":-22.083689,"twenty":-17.029168,"median":-11.065029,"eighty":-6.43177,"marketCap":2469729337},{"date":"2023-07-07","current":-22.276624,"twenty":-17.057464,"median":-11.105684,"eighty":-6.438144,"marketCap":2491306274},{"date":"2023-07-14","current":-22.425036,"twenty":-17.087456,"median":-11.138265,"eighty":-6.45101,"marketCap":2507903917},{"date":"2023-07-21","current":-21.866018,"twenty":-17.119501,"median":-11.178937,"eighty":-6.45946,"marketCap":2445386127},{"date":"2023-07-28","current":-20.376952,"twenty":-17.14627,"median":-11.22673,"eighty":-6.46789,"marketCap":2278856438},{"date":"2023-08-04","current":-21.772024,"twenty":-17.217199,"median":-11.335981,"eighty":-6.476813,"marketCap":2434874286},{"date":"2023-08-11","current":-22.068848,"twenty":-17.249506,"median":-11.376127,"eighty":-6.485785,"marketCap":2468069573},{"date":"2023-08-18","current":-21.775894,"twenty":-17.26265,"median":-11.556183,"eighty":-6.498237,"marketCap":2515442397},{"date":"2023-08-25","current":-22.579734,"twenty":-17.33271,"median":-11.680392,"eighty":-6.506131,"marketCap":2608298029},{"date":"2023-09-01","current":-23.888984,"twenty":-17.483375,"median":-11.732424,"eighty":-6.522472,"marketCap":2759535945},{"date":"2023-09-08","current":-23.975625,"twenty":-17.503637,"median":-11.779701,"eighty":-6.543409,"marketCap":2769544336},{"date":"2023-09-15","current":-24.423273,"twenty":-17.583044,"median":-11.85686,"eighty":-6.575679,"marketCap":2821254359},{"date":"2023-09-22","current":-23.325814,"twenty":-17.65422,"median":-11.925494,"eighty":-6.578828,"marketCap":2694481400},{"date":"2023-09-29","current":-23.200665,"twenty":-17.772652,"median":-11.988554,"eighty":-6.581625,"marketCap":2680024835},{"date":"2023-10-06","current":-22.825219,"twenty":-17.880201,"median":-12.016525,"eighty":-6.590608,"marketCap":2636655138},{"date":"2023-10-13","current":-7.070908,"twenty":-17.909563,"median":-12.014586,"eighty":-6.611795,"marketCap":816795950},{"date":"2023-10-20","current":-5.992703,"twenty":-17.880201,"median":-11.976041,"eighty":-6.609411,"marketCap":692247078},{"date":"2023-10-27","current":-5.63651,"twenty":-17.841444,"median":-11.946624,"eighty":-6.58347,"marketCap":651101469},{"date":"2023-11-03","current":-6.41147,"twenty":-17.798894,"median":-11.887589,"eighty":-6.526817,"marketCap":740620971},{"date":"2023-11-10","current":-6.77729,"twenty":-17.789965,"median":-11.82287,"eighty":-6.559209,"marketCap":782878624},{"date":"2023-11-17","current":-6.724365,"twenty":-17.782933,"median":-11.746423,"eighty":-6.57702,"marketCap":804449266},{"date":"2023-11-24","current":-7.60915,"twenty":-17.764215,"median":-11.708067,"eighty":-6.579297,"marketCap":910297854},{"date":"2023-12-01","current":-7.795421,"twenty":-17.712824,"median":-11.593015,"eighty":-6.582548,"marketCap":932581767},{"date":"2023-12-08","current":-9.20642,"twenty":-17.667352,"median":-11.477549,"eighty":-6.594718,"marketCap":1101382409},{"date":"2023-12-15","current":-10.393894,"twenty":-17.656792,"median":-11.345602,"eighty":-6.610002,"marketCap":1243442356},{"date":"2023-12-22","current":-10.393894,"twenty":-17.653195,"median":-11.232635,"eighty":-6.611814,"marketCap":1243442356},{"date":"2023-12-29","current":-11.185544,"twenty":-17.650119,"median":-11.210572,"eighty":-6.611872,"marketCap":1338148987},{"date":"2024-01-05","current":-10.631389,"twenty":-17.631629,"median":-11.188816,"eighty":-6.612311,"marketCap":1271854345},{"date":"2024-01-12","current":-10.51497,"twenty":-17.607747,"median":-11.177301,"eighty":-6.614175,"marketCap":1257926900},{"date":"2024-01-19","current":-10.044637,"twenty":-17.595377,"median":-11.143097,"eighty":-6.627287,"marketCap":1201660019},{"date":"2024-01-26","current":-10.272818,"twenty":-17.577711,"median":-11.122573,"eighty":-6.646111,"marketCap":1228957812},{"date":"2024-02-02","current":-9.769888,"twenty":-17.54931,"median":-11.065029,"eighty":-6.655858,"marketCap":1168791247},{"date":"2024-02-09","current":-8.661579,"twenty":-17.523002,"median":-11.036489,"eighty":-6.674356,"marketCap":1036201963},{"date":"2024-02-16","current":-9.970129,"twenty":-17.508363,"median":-10.963741,"eighty":-6.68355,"marketCap":1192746454},{"date":"2024-02-23","current":-11.274022,"twenty":-17.503637,"median":-10.963741,"eighty":-6.685735,"marketCap":1348733846},{"date":"2024-03-01","current":-9.907861,"twenty":-17.499475,"median":-10.97599,"eighty":-6.689569,"marketCap":1503607043},{"date":"2024-03-08","current":-13.693736,"twenty":-17.484481,"median":-11.032612,"eighty":-6.692096,"marketCap":2078147664},{"date":"2024-03-15","current":-12.434807,"twenty":-17.483928,"median":-11.06341,"eighty":-6.692292,"marketCap":1887093841},{"date":"2024-03-22","current":-11.785126,"twenty":-17.46609,"median":-11.105684,"eighty":-6.692925,"marketCap":1788498876},{"date":"2024-03-28","current":-11.108185,"twenty":-17.403588,"median":-11.09849,"eighty":-6.695426,"marketCap":1685767059},{"date":"2024-04-05","current":-10.435788,"twenty":-17.38818,"median":-11.080926,"eighty":-6.72092,"marketCap":1583724718},{"date":"2024-04-12","current":-9.922403,"twenty":-17.334251,"median":-11.054626,"eighty":-6.724067,"marketCap":1505814011},{"date":"2024-04-19","current":-9.345654,"twenty":-17.330399,"median":-11.028735,"eighty":-6.724365,"marketCap":1418287153},{"date":"2024-04-26","current":-8.625706,"twenty":-17.291878,"median":-10.963741,"eighty":-6.769377,"marketCap":1309028562},{"date":"2024-05-03","current":-8.981124,"twenty":-17.284393,"median":-10.935543,"eighty":-6.772729,"marketCap":1362966347},{"date":"2024-05-10","current":-9.477797,"twenty":-17.264914,"median":-10.911023,"eighty":-6.77729,"marketCap":1438340945},{"date":"2024-05-17","current":-7.996231,"twenty":-17.259255,"median":-10.873245,"eighty":-6.784548,"marketCap":1433500375},{"date":"2024-05-24","current":-7.294198,"twenty":-17.259255,"median":-10.8249,"eighty":-6.799538,"marketCap":1307645542},{"date":"2024-05-31","current":-7.062759,"twenty":-17.255885,"median":-10.76904,"eighty":-6.801777,"marketCap":1266154938},{"date":"2024-06-07","current":-8.227671,"twenty":-17.250613,"median":-10.740823,"eighty":-6.813105,"marketCap":1474990979},{"date":"2024-06-14","current":-9.49673,"twenty":-17.249506,"median":-10.688857,"eighty":-6.819613,"marketCap":1702497792},{"date":"2024-06-21","current":-8.40125,"twenty":-17.248735,"median":-10.652344,"eighty":-6.826938,"marketCap":1506108932},{"date":"2024-06-28","current":-9.026137,"twenty":-17.249506,"median":-10.688857,"eighty":-6.898715,"marketCap":1618133563},{"date":"2024-07-05","current":-8.45911,"twenty":-17.249506,"median":-10.688857,"eighty":-6.92169,"marketCap":1516481583},{"date":"2024-07-12","current":-9.581591,"twenty":-17.249506,"median":-10.688857,"eighty":-6.950519,"marketCap":1717711013},{"date":"2024-07-15","current":-9.905606,"twenty":-17.249506,"median":-10.688857,"eighty":-6.973879,"marketCap":1775797859},{"date":"2024-08-02","current":-10.164047,"twenty":-17.259255,"median":-10.8249,"eighty":-7.007731,"marketCap":1822129034},{"date":"2024-08-09","current":-9.616307,"twenty":-17.259255,"median":-10.8249,"eighty":-7.007731,"marketCap":1723934604},{"date":"2024-08-16","current":-8.2701,"twenty":-17.259255,"median":-10.8249,"eighty":-7.007731,"marketCap":1688555937},{"date":"2024-08-23","current":-8.878796,"twenty":-17.259255,"median":-10.8249,"eighty":-7.007731,"marketCap":1812836986},{"date":"2024-08-30","current":-9.144037,"twenty":-17.259255,"median":-10.8249,"eighty":-7.007731,"marketCap":1866992975},{"date":"2024-09-06","current":-8.960409,"twenty":-17.259255,"median":-10.8249,"eighty":-7.007731,"marketCap":1829500367},{"date":"2024-09-13","current":-8.739374,"twenty":-17.259255,"median":-10.8249,"eighty":-7.007731,"marketCap":1784370377},{"date":"2024-09-20","current":-9.521497,"twenty":-17.259255,"median":-10.8249,"eighty":-7.026851,"marketCap":1944061112},{"date":"2024-09-27","current":-9.977168,"twenty":-17.259255,"median":-10.8249,"eighty":-7.042028,"marketCap":2037098322},{"date":"2024-10-04","current":-9.402478,"twenty":-17.259255,"median":-10.8249,"eighty":-7.057579,"marketCap":1919760348},{"date":"2024-10-11","current":-9.888754,"twenty":-17.259255,"median":-10.8249,"eighty":-7.069165,"marketCap":2019046326},{"date":"2024-10-18","current":-10.480447,"twenty":-17.259255,"median":-10.8249,"eighty":-7.079838,"marketCap":2139855838},{"date":"2024-10-25","current":-9.776537,"twenty":-17.259255,"median":-10.8249,"eighty":-7.119268,"marketCap":1996134177},{"date":"2024-10-31","current":-10.439641,"twenty":-17.259255,"median":-10.8249,"eighty":-7.161665,"marketCap":2131524147},{"date":"2024-11-08","current":-11.857664,"twenty":-17.259255,"median":-10.907052,"eighty":-7.186493,"marketCap":2421050391},{"date":"2024-11-15","current":-8.75645,"twenty":-17.259255,"median":-10.907052,"eighty":-7.240168,"marketCap":2077222644},{"date":"2024-11-22","current":-9.180149,"twenty":-17.259255,"median":-10.907052,"eighty":-7.266613,"marketCap":2177733417},{"date":"2024-11-29","current":-9.444961,"twenty":-17.259255,"median":-10.907052,"eighty":-7.299172,"marketCap":2240552650},{"date":"2024-12-06","current":-8.738796,"twenty":-17.259255,"median":-10.907052,"eighty":-7.31339,"marketCap":2073034695},{"date":"2024-12-13","current":-8.541658,"twenty":-17.259255,"median":-10.907052,"eighty":-7.346896,"marketCap":2026269266},{"date":"2024-12-20","current":-8.35629,"twenty":-17.259255,"median":-10.907052,"eighty":-7.425464,"marketCap":1982295803},{"date":"2024-12-27","current":-8.500465,"twenty":-17.259255,"median":-10.907052,"eighty":-7.487863,"marketCap":2016497385},{"date":"2025-01-03","current":-8.262135,"twenty":-17.259255,"median":-10.907052,"eighty":-7.504888,"marketCap":1959960075},{"date":"2025-01-10","current":-7.697202,"twenty":-17.259255,"median":-10.911023,"eighty":-7.523443,"marketCap":1825945711},{"date":"2025-01-17","current":-7.064596,"twenty":-17.259255,"median":-10.911023,"eighty":-7.523443,"marketCap":1675877543},{"date":"2025-01-24","current":-7.697202,"twenty":-17.259255,"median":-10.911023,"eighty":-7.526686,"marketCap":1825945711},{"date":"2025-01-31","current":-16.288881,"twenty":-17.259255,"median":-10.944954,"eighty":-7.530702,"marketCap":3864080833},{"date":"2025-02-07","current":-17.657031,"twenty":-17.314301,"median":-11.032612,"eighty":-7.530702,"marketCap":4188636174},{"date":"2025-02-14","current":-15.819029,"twenty":-17.33194,"median":-11.08486,"eighty":-7.530702,"marketCap":3752621635},{"date":"2025-02-21","current":-16.252823,"twenty":-17.33194,"median":-11.130344,"eighty":-7.536241,"marketCap":3855527164},{"date":"2025-02-28","current":-15.343462,"twenty":-17.33194,"median":-11.177301,"eighty":-7.576104,"marketCap":3639806684},{"date":"2025-03-07","current":-13.794378,"twenty":-17.33271,"median":-11.232635,"eighty":-7.613734,"marketCap":3477010989},{"date":"2025-03-14","current":-14.170273,"twenty":-17.33271,"median":-11.35311,"eighty":-7.676374,"marketCap":3571758942},{"date":"2025-03-21","current":-14.107097,"twenty":-17.33271,"median":-11.477549,"eighty":-7.676374,"marketCap":3555834916},{"date":"2025-03-28","current":-13.765949,"twenty":-17.33271,"median":-11.680392,"eighty":-7.676374,"marketCap":3469845178},{"date":"2025-04-04","current":-12.631948,"twenty":-17.33271,"median":-11.708067,"eighty":-7.676374,"marketCap":3184008918},{"date":"2025-04-11","current":-10.998861,"twenty":-17.33194,"median":-11.593015,"eighty":-7.677946,"marketCap":2772372856},{"date":"2025-04-17","current":-11.82646,"twenty":-17.33194,"median":-11.559247,"eighty":-7.677946,"marketCap":2980977592},{"date":"2025-04-25","current":-12.947826,"twenty":-17.33271,"median":-11.525934,"eighty":-7.676374,"marketCap":3263629046},{"date":"2025-05-02","current":-14.312418,"twenty":-17.33271,"median":-11.525934,"eighty":-7.676374,"marketCap":3607587999}],"updateTime":1746299581311}}}